The store will not work correctly when cookies are disabled.
(4S)-4-[[(5-chloro-8-quinolyl)methylamino]methyl]-1-methyl-piperidin-2-one
ID: ALA5089996
PubChem CID: 166631747
Max Phase: Preclinical
Molecular Formula: C17H20ClN3O
Molecular Weight: 317.82
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CC[C@H](CNCc2ccc(Cl)c3cccnc23)CC1=O
Standard InChI: InChI=1S/C17H20ClN3O/c1-21-8-6-12(9-16(21)22)10-19-11-13-4-5-15(18)14-3-2-7-20-17(13)14/h2-5,7,12,19H,6,8-11H2,1H3/t12-/m0/s1
Standard InChI Key: LODXNPITSUCBCC-LBPRGKRZSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
-2.8556 0.6191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1410 1.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4291 0.6195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4291 -0.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1392 -0.6173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8556 -0.2092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1349 -1.4393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8466 -1.8560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5603 -1.4515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5701 -0.6276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5698 1.0315 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.7149 -0.6179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0008 -0.2055 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7134 -0.6179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4276 -0.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4276 0.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1417 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8559 0.6190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8559 -0.2056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1417 -0.6179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1417 1.8560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5701 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
5 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
6 10 1 0
1 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
15 14 1 6
16 15 1 0
17 16 1 0
18 17 1 0
19 18 1 0
20 19 1 0
15 20 1 0
17 21 2 0
18 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 317.82 | Molecular Weight (Monoisotopic): 317.1295 | AlogP: 2.85 | #Rotatable Bonds: 4 |
Polar Surface Area: 45.23 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.63 | CX LogP: 1.83 | CX LogD: -0.36 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.94 | Np Likeness Score: -1.09 |
References
1. Levit Kaplan A, Strachan RT, Braz JM, Craik V, Slocum S, Mangano T, Amabo V, O'Donnell H, Lak P, Basbaum AI, Roth BL, Shoichet BK.. (2022) Structure-Based Design of a Chemical Probe Set for the 5-HT5A Serotonin Receptor., 65 (5.0): [PMID:35195401] [10.1021/acs.jmedchem.1c02031] |